index - Plateforme d’immortalisation MyoLine – CRM

Dernières publications

Chiffres clés

Chargement de la page

Open Access

87 %

Mots clés

Human Gene therapy Bile acid Lamin A/C nuclei DNM2 Cell Therapy Human artificial chromosomes Duchenne Muscular Dystrophy MT RNA/DNA Editing CDNA synthesis Motor neuron FoxO Neuromuscular junction Glucose DMD Duchenne muscular dystrophy Dynamin 2 Gel electrophoresis 3D co-culture DM1 myoblasts Antisense oligonucleotide CXCL12 Flavonoid Migration Myotube Mdx CLS LTβR Immortalized dystrophic canine myoblast Autophagosome Eteplirsen Actin Exon Skipping LRP4 Cell biology Adhesion Machine learning Insulin Antisense morpholino Exon skipping DsDNA break repair Expanded repeats Drisapersen Computer software BAF Fear response Endocytosis Canine X-linked muscular dystrophy in Japan CXMD J Dominant centronuclear myopathy Fibrosis Exon-skipping ICU-acquired weakness CXCR4 Acetylcholine receptor subunit epsilon Centronuclear myopathy MSCs Adeno-associated viral vector Gut microbiota Allele-specific silencing Allele-specific silencing therapy Gene Therapy Laminographie Dystrophin FSHD Fibroblast Chromatin Skeletal muscle Myotonic dystrophy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Differentiation CMS ITSN1 Lymphotoxin-β-receptor Cell-penetrating peptide CRISPR/Cas9 Emerin Clinical trial candidate screening CFTR correctors Muscle Conjugation CTG⋅CAGn repeat Folding-defective proteins Immortalisation Human muscle stem/progenitor cells HDMD/Dmd-null mice Lamina-associated domain Becker muscular dystrophy Gene network analysis Glucocorticoid-induced muscle atrophy Exondys 51 Developmental biology Autophagy BMD Coculture DiPRO1 RNA interference Myogenesis KLF15 Alternative splicing Atrial cardiac defects